Dear Voornaam, Welcome to your weekly Cancer Research UK Research Update email. There’s just over a week left to get your nominations in for our new, annual Cancer Research Horizons Innovation & Entrepreneurship Awards, celebrating the UK’s most innovative and enterprising efforts in oncology. We’re looking for nominees who are translating discoveries into novel treatments, diagnostics and medical devices that benefit cancer patients, across categories including: • Woman Entrepreneur of the Year • Early-career Entrepreneur of the Year • New Startup of the Year • Startup Achievement of the Year • Further, Faster, Together (Industry-Academia Collaboration) Nominate yourself or a fellow entrepreneur or innovative startup company for the perfect opportunity to showcase your work, receive funding and sector-wide recognition at our exclusive award ceremony, held at the Royal Society in London on 6 December. Nominations must be submitted by 28 October, so don’t delay. Find out more and submit your nominations |
|
---|
|
---|
|
|
Funding & Research Opportunities |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
|
|
LAST CHANCE TO GET YOUR TICKET TO OUR LUNG CANCER CONFERENCE There are only four weeks until our Lung Cancer Conference. Returning in-person to Manchester on 15–17 November, the conference will bring together outstanding researchers, leaders and patient advocates in lung cancer research and associated disciplines from around the world. Don’t miss the opportunity to re-connect with the lung cancer research community and hear more about the latest developments spanning the research pipeline. Attend thought-provoking sessions on how lung cancer develops in never smokers, the transformative shifts underway in early detection, and the new technological approaches to monitoring and treatment. Spaces are limited – register by 1 November to guarantee your place. |
|
---|
|
---|
|
|
REFLECTING ON DIVERSITY IN FUNDING THIS BLACK HISTORY MONTH Especially during Black History Month, we want to have honest conversations about diversity in research. In 2021 we made an action plan to improve diversity within our research community. Earlier this year we published our second report on diversity in our research funding, in which we see some improvements in equity, but we still have a long way to go. To tackle these inequalities, we introduced some strategic opportunities, events and partnerships. Only last week we held the first Black in Cancer conference, which brought Black researchers together from around the globe. A diverse and inclusive research community allows us to draw on a wide range of ideas from a variety of backgrounds, which maximises scientific innovation and creativity. |
|
---|
|
---|
|
|
NEW PREVENTION FUNDING SCHEME FOR DISCOVERY SCIENTISTS We're introducing a Biology to Prevention Award to support collaborative, translational research that will build a greater biological and mechanistic understanding of cancer aetiology, risk and incidence and ultimately lead to future preventive interventions. This award can fund pilot studies (around £100k over 1-year) through to larger projects (up to £600k for up to 5 years). The current round is open until 12 January 2023. |
|
---|
| BRINGING BIOLOGY TO PREVENTION RESEARCH WEBINAR Join us at 2pm on 23 November for a webinar to learn more about our new Biology to Prevention Award. You can put your questions to Professors Kay-Tee Khaw and Karen Brownour (Chair and Vice-chair of Prevention and Population Research Committee, respectively) and Dave Crosby, our Head of Prevention and Early Detection Research, as they introduce the new award, how it fits into our research strategy, and provide tips on what makes a successful application. |
|
---|
|
---|
|
|
DISCOVERY TO TRANSLATION – A JOURNEY WORTH TAKING There are many challenges when translating your research into patient impact – but it is always worth overcoming them says Catharine West, founder of ManTRa Diagnostics. In her academic research Catharine developed hypoxia-associated gene signatures for lung cancers, which allow for more targeted treatment and can improve patient prognosis. Commercialisation through ManTRa Diagnostics has made her signature more attractive to funders and is accelerating the journey of bringing the diagnostics to cancer patients. We talked to Catharine about her experience with founding ManTRa Diagnostics, the challenges she has faced, and her advice on starting a spinout company. |
|
---|
|
---|
|
|
ACCESS SEED-FUNDING WITH CANCER RESEARCH HORIZONS Cancer Research Horizons is providing funding to researchers and early-stage startups to help advance innovative ideas in oncology. Work with us and receive rapid access early-stage validation, Pre-Seed and Seed capital, as well as access to commercial advice and guidance through our network of experts, mentors and management teams. We’ll also support you with introductions to co-investors to maximise the chances of your ideas becoming financially attractive to investors. |
|
---|
| APPLICATIONS OPEN FOR MRC CANCERS OF UNMET NEED SANDPIT WORKSHOP The MRC has opened a call for applications to attend a sandpit workshop in cancers of unmet need, including brain, lung, oesophageal, pancreatic, stomach and liver cancer. The workshop will bring together researchers from varied disciplines, including medical, data, engineering and physical sciences, to co-develop innovative and high-risk, high-reward technologies to better understand cancers of unmet need and treat them more effectively. Apply by 8 November 2022; the workshop will take place in Manchester on 18–19 January 2023. |
|
---|
|
---|
|
|
OPT INTO OUR REGISTERED REPORTS FUNDING PARTNERSHIP Application deadlines for our Early Detection and Diagnosis Research and Prevention and Population Research Project Awards are getting closer – did you know that you can access our Registered Reports funding partnership through these schemes? You can also opt in when you apply to the newly launched Biology to Prevention Awards. Registered Reports are a novel method of publishing, making research methodology and findings more accessible by de-linking results and publication. Opt in to our pilot and help us improve research quality and transparency. |
|
---|
|
---|
|
|
| Manchester, UK 15 November 2022 |
|
---|
|
---|
| Online 2:00 PM 23 November 2022 |
|
---|
|
---|
| East Sussex, UK 04 December 2022 |
|
---|
|
---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
---|
|
---|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
---|
| |
---|
|
|
|